- Advertisement -
Drugmaker AstraZeneca said that its COVID-19 antibodies cocktail has helped cut the risk of severe disease or deaths in a late-stage study.
The pharma company announced the results on Monday, marking a boost in its effort to develop coronavirus medicines…

